Community resources and publications
TAG hepatitis C pipeline report
Tracy Swans 2011 Hepatitis C Treatment Pipeline Report produced by the Treatment Action Group in New York is a must-read. This clear concise and comprehensive overview of research shows that hepatitis C treatments in 2011 have a similarly dramatic potential as HAART had for HIV in 1996.
Issues covered include diagnostics, drug resistance, access to, and delivery of treatment, and population-specific focus on the new HCV drugs, as well as research recommendations.
FDA approval of two hepatitis C-specific protease inhibitors, the first of the coming wave of oral antiviral drugs, is anticipated later this year. Dozens of other drugs are in development.